Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Special Drug Use-Results Survey of DEMSER in Pheochromocytoma
jRCT2031240474Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metyrosine in pheochromocytoma, sponsored by Ono Pharmaceutical. Primary endpoints: Safety - adverse drug reactions and infections, Overall improvement and 2 more. Started Jun 2019; status: recruiting.
02
Drugs
metyrosine
03
Conditions
pheochromocytoma
Beyond the preview
Go deeper on jRCT2031240474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240474.